Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

311
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
311
Long-term Depression01:05

Long-term Depression

31.3K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
31.3K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

183
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
183
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

148
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
148

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhibition of matrine against gastric cancer cell line MNK45 growth and its anti-tumor mechanism.

Molecular biology reports·2011
Same author

Evolution of activation patterns during long-duration ventricular fibrillation in pigs.

American journal of physiology. Heart and circulatory physiology·2011
Same author

A new feruloyl amide derivative from the fruits of Tribulus terrestris.

Natural product research·2011
Same author

High-amylose rice improves indices of animal health in normal and diabetic rats.

Plant biotechnology journal·2011
Same author

The cross-validated AUC for MCP-logistic regression with high-dimensional data.

Statistical methods in medical research·2011
Same author

All-optical virtual private network and ONUs communication in optical OFDM-based PON system.

Optics express·2011
Same journal

Astrocyte heterogeneity and hierarchical information flow: reframing glial computation.

Frontiers in cellular neuroscience·2026
Same journal

Cognitive and neurodevelopmental outcomes in spinal muscular atrophy: a scoping review.

Frontiers in cellular neuroscience·2026
Same journal

SMΝΔ7 mice show breathing and airflow defects with significant pathology of respiratory and oral tract tissues.

Frontiers in cellular neuroscience·2026
Same journal

Effects of volatile anesthetics on peripheral nerve regeneration in a sciatic cut repair murine model.

Frontiers in cellular neuroscience·2026
Same journal

Correction: Acetylcholine receptor stimulation activates protein kinase C mediated internalization of the dopamine transporter.

Frontiers in cellular neuroscience·2026
Same journal

Defining spinal motor neuron subtypes across development: from embryonic specification to postnatal maturation.

Frontiers in cellular neuroscience·2026
See all related articles

Related Experiment Video

Updated: Aug 20, 2025

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

15.3K

Low and high dose methamphetamine differentially regulate synaptic structural plasticity in cortex and hippocampus.

Jiuyang Ding1,2, Jian Huang3, Xiang Tang4,5,6,7,8

  • 1School of Forensic Medicine, Guizhou Medical University, Guiyang, China.

Frontiers in Cellular Neuroscience
|November 21, 2022
PubMed
Summary
This summary is machine-generated.

Low dose methamphetamine (METH) enhances synaptic structure and memory, while high doses cause neurodegeneration. These effects are linked to differential regulation of Rac1 and Cdc42 signaling pathways.

Keywords:
hippocampusmethamphetamineprefrontal cortexstructural plasticitysynapse

More Related Videos

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

12.2K
A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
07:56

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices

Published on: August 11, 2021

3.4K

Related Experiment Videos

Last Updated: Aug 20, 2025

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

15.3K
Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

12.2K
A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
07:56

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices

Published on: August 11, 2021

3.4K

Area of Science:

  • Neuroscience
  • Pharmacology
  • Cell Biology

Background:

  • Methamphetamine (METH) is a psychostimulant known to affect synaptic structure and neurotransmission.
  • High doses of METH can lead to neurodegeneration, but the impact of low doses on synaptic plasticity and underlying mechanisms is not well understood.

Purpose of the Study:

  • To investigate the differential effects of low and high doses of METH on synaptic structure in the hippocampus and prefrontal cortex (PFC).
  • To elucidate the molecular mechanisms, specifically the roles of Rac1 and Cdc42, involved in METH-induced synaptic alterations.

Main Methods:

  • Administration of low (2 mg/kg) and high (10 mg/kg) doses of METH to assess synaptic structure, neuronal numbers, and memory function.
  • Histological analysis of hippocampus and PFC to evaluate synaptic morphology and gliosis.
  • Molecular analysis of Rac1 and Cdc42 signaling pathways.

Main Results:

  • Low dose METH promoted spine formation, increased synaptic numbers, elongated postsynaptic density, and improved memory function.
  • High dose METH induced synaptic degeneration, neuronal loss, memory impairment, and gliosis in the PFC and hippocampus.
  • Low dose METH inactivated Rac1 and activated Cdc42, whereas high dose METH inactivated Cdc42 and activated Rac1.

Conclusions:

  • Low and high doses of METH exert opposing effects on synaptic plasticity in the cortex and hippocampus.
  • The differential regulation of Rac1 and Cdc42 signaling pathways mediates the distinct synaptic outcomes observed with varying METH doses.